C0754471||TREK-1 (K2P2.1) K(+) channels
C0004238||atrial fibrillation
C0018801||heart failure
C0004238||Atrial fibrillation
C0004238||Atrial fibrillation
C0003811||cardiac arrhythmia
C0018801||Concomitant heart failure
C0018801||heart failure
C1315011||challenge
C0034954||atrial electrical refractoriness
C0018787||non-failing hearts
C0013081||downregulation
C1371280||atrial repolarizing
C0754471||TREK-1 (K2P2.1) K(+) channels
C3658220||electrical remodeling
C0004238||Atrial fibrillation
C0018801||heart failure
C1517499||TREK-1 gene transfer
C1882115||normalization
C0428938||atrial effective refractory periods
C0004238||Atrial fibrillation
C2986480||subset
C0694539||chronic AF
C0018801||heart failure
C0754471||atrial TREK-1
C0035696||mRNA
C0225860||left atrium
C0225844||right atrium
C0232201||sinus rhythm
C0232201||sinus rhythm
C0080105||subjects
C0086418||Human
C0243095||findings
C0004238||atrial tachypacing-induced AF
C0080310||left ventricular function
C0754471||TREK-1
C0035696||mRNA
C0754471||protein
C0004238||Atrial fibrillation
C0003062||animals
C0232201||sinus rhythm
C0013081||Downregulation
C1371280||repolarizing
C0754471||TREK-1 channels
C0428938||atrial effective refractory periods
C0302523||observations
C0086418||humans
C0018801||heart failure
C0039005||pigs
C0034656||randomized
C0017296||atrial Ad-TREK-1 gene therapy
C0032042||sham treatment
C1517499||Gene transfer
C0754471||TREK-1 protein
C0428938||atrial effective refractory period
C0754471||Ad-TREK-1
C0232201||sinus rhythm
C0004238||Atrial fibrillation
C0003062||animals
C0004238||Atrial fibrillation
C0754471||TREK-1
C0013081||downregulation
C1517499||Ad-TREK-1 transfer
C0087111||mechanistic and potential therapeutic
C0754471||TREK-1 channels
C1515021||subgroup
C0004238||Atrial fibrillation
C0018801||heart failure
C0428938||atrial effective refractory periods
C0017296||TREK-1 gene therapy
C0004238||Atrial fibrillation